Estimated insulin sensitivity predicts regression of albuminuria in Type 1 diabetes

Diabetic Medicine

Volumn 32, Issue 2, 2015, Pages 257-261

  Bjornstad, P ^a   Maahs, D M ^a,b   Johnson, R J ^a   Rewers, M ^a,b   Snell Bergeon, J K ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URATE OXIDASE; URIC ACID; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ALBUMINURIA; ARTICLE; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; URINARY EXCRETION; COHORT ANALYSIS; COLORADO; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE COURSE; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADULT; ALBUMINURIA; COHORT STUDIES; COLORADO; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84921433927     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12572     Document Type: Article

References (19)

1. Maahs DM, Rewers M. Editorial: Mortality and renal disease in type 1 diabetes mellitus-progress made, more to be done. J Clin Endocrinol Metabol 2006; 91: 3757-3759.
2. Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2010; 53: 2312-2319.
3. Bjornstad P, Cherney D, Maahs DM. Early Diabetic Nephropathy in Type 1 Diabetes - New Insights. Curr Opin Endocrinol Diabetes Obes 2014; 21: 279-286.
4. Marshall SM. Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s? Diabetologia 2012; 55: 2301-2306.
5. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003; 348: 2285-2293.
6. Bjornstad P, Snell-Bergeon JK, Rewers M, Jalal D, Chonchol MB, Johnson RJ, Maahs DM. Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care 2013; 36: 3678-3683.
7. Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J et al. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 2005; 28: 301-306.
8. Bishop FK, Maahs DM, Snell-Bergeon JK, Ogden LG, Kinney GL, Rewers M. Lifestyle risk factors for atherosclerosis in adults with type 1 diabetes. Diab Vasc Dis Res 2009; 6: 269-275.
9. Kriska AM, Knowler WC, LaPorte RE, Drash AL, Wing RR, Blair SN et al. Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 1990; 13: 401-411.
10. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20-29.
11. Maahs DM, Jalal D, McFann K, Rewers M, Snell-Bergeon JK. Systematic shifts in cystatin C between 2006 and 2010. Clin J Am Soc Nephrol 2011; 6: 1952-1955.
12. Bjornstad P, Snell-Bergeon JK, Rewers M, Jalal D, Chonchol MB, Johnson RJ et al. Early diabetic nephropathy: A complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care 2013; 36: 3678-3683.
13. Bjornstad P, Snell-Bergeon JK, McFann K, Wadwa RP, Rewers M, Rivard CJ et al. Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes. J Diabetes Complications 2013; 28: 298-304.
14. Snell-Bergeon J, Maahs DM, Schauer I. A method for estimating insulin sensitivity in adults with type 1 diabetes. Diabetes 2010; 59(Suppl. 1): A295-295.
15. Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH et al. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes 2011; 60: 306-314.
16. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993; 342: 883-887.
17. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002; 62: 963-970.
18. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH. Diabetic nephropathy. Diabetes Care 2003; 26(Suppl. 1): S94-98.
19. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-2515.